F Boros, L Vécsei - Expert opinion on investigational drugs, 2020 - Taylor & Francis
Introduction The diverse neuro-and immunomodulatory effects of kynurenine pathway (KP) enzymes and metabolites exert offer possibilities for intervention in diseases such as …
Abstract l‐4‐Chlorokynurenine (l‐4‐Cl‐Kyn) is a neuropharmaceutical drug candidate that is in development for the treatment of major depressive disorder. Recently, this amino acid was …
AS Vasilchenko, WT Julian, OA Lapchinskaya… - Frontiers in …, 2020 - frontiersin.org
In this work, we report the isolation and detailed functional characterization for the new non- ribosomally synthesized antibiotic 5812-A/C, which was derived from metabolites of …
AP Tyurin, VA Alferova, AS Paramonov… - Angewandte Chemie …, 2021 - Wiley Online Library
We report a novel family of natural lipoglycopeptides produced by Streptomyces sp. INA‐Ac‐ 5812. Two major components of the mixture, named gausemycins A and B, were isolated …
Three natural glycosylated macrolide compounds, known irumamycin 1 and X-14952B 2, as well as new isoirumamycin 3, were isolated from ethyl acetate mycelium extract of …
РЕФЕРАТ Метою даної кваліфікаційної роботи є розробка апаратурної та технологічної схеми біосинтезу вторинного метаболіту фунгіциду розеофунгіну з використанням …
Introduction: The diverse neuro-and immunomodulatory effects of kynurenine pathway (KP) enzymes and metabolites exert offer possibilities for intervention in diseases such as …
Abstract L-4-Chlorokynurenine (L-4-Cl-Kyn) is a neuropharmaceutical drug candidate in development for the treatment of major depressive disorder. Recently, this amino acid was …